Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.
Explore these studies to deepen your understanding of the subject.
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
R. J. Kelly, B. V. Landon, et al.
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCESO1 trial
J. Qin, L. Xue, et al.
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial
B. Besse, E. Pons-tostivint, et al.
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial
P. G. M. D. Gooyer, Y. L. Verschoor, et al.
